
News|Articles|November 19, 2007
Latebreakers: FDA gives nod to OTC Zyrtec-D for allergies
This drug combines an antihistamine with a nasal decongestant.
Advertisement
The FDA has approved McNeil Consumer Healthcare's Zyrtec-D (cetirizine HCl 5 mg/pseudoephedrine HCl 120 mg), an allergy drug, for OTC use in adults and children 12 years and older. This drug combines an antihistamine with a nasal decongestant. Available as a prescription drug since 2001, Zyrtec-D is now approved as an OTC for the relief of symptoms due to hay fever or other respiratory allergies such as runny nose; sneezing; itchy, watery eyes; itching of the nose or throat; and nasal congestion. Zyrtec-D is also used for reducing swelling of the nasal passages, relief of sinus congestion and pressure, and restoring freer breathing through the nose.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
ICER Report Finds GLP-1s Are Cost-Effective But Warns of Budget Strain
3
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
4
Pharmacists Want Prescribing Authority With Proper Training, Support
5






























